Margo Shoup, MD, MBA, FACS will join Orlando Health as the new president of Orlando Health Cancer Institute and vice president of Orlando Health, where she will have oversight of the organization’s oncology services and strategic growth and development efforts.
Dr. Shoup comes to Orlando Health Cancer Institute from Nuvance Health in Connecticut, where she served as senior vice president and chair of the Nuvance Health Cancer Institute. Before arriving at Nuvance, she was the medical leader of Oncology for Northwestern Medicine in Chicago, Illinois.
“We’re very pleased to have Dr. Shoup bring her considerable experience as a clinician and executive leader to Orlando Health,” says Daniel Buchholz, MD, interim president of Orlando Health Cancer Institute. “Her leadership style and personality will be a great fit into our culture, and she will continue to promote the high-quality innovative care we provide to our patients.”
A graduate of Northwestern University, Feinberg School of Medicine in Chicago, Dr. Shoup completed a general surgery residency and research fellowship at Loyola University in Maywood, Illinois and a surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York, New York.
After finishing her training, Dr. Shoup returned to Loyola University Medical Center, where from 2002 to 2012, she held the titles of Professor of Surgery, Chief of the Division of Surgical Oncology, Vice Chairman for Clinical Outcomes Research in the Department of Surgery and the Assistant Dean for Clinical and Translational Research for the Stritch School of Medicine.
Dr. Shoup earned an MBA at University of Massachusetts in Amherst in 2020, and currently has more than 200 peer-reviewed publications and presentations. She has also served as principal investigator on several nationally funded and investigator-initiated research trials. Dr. Shoup served as Director with the American Board of Surgery and continues to be an oral board examiner.
She will take the reins of Orlando Health Cancer Institute on June 1, 2021 from Daniel Buchholz, MD, who has been serving as interim president since the retirement of Mark Roh, M.D., as president in April 2020.
Orlando Health, headquartered in Orlando, Florida, is a not-for-profit healthcare organization with $7.1 billion of assets under management that serves the southeastern United States.
Founded more than 100 years ago, the healthcare system is recognized around the world for its pediatric and adult Level One Trauma program as well as the only state-accredited Level Two Adult Trauma Center in Pinellas County. It is the home of the nation’s largest neonatal intensive care unit under one roof, the only system in the southeast to offer open fetal surgery to repair the most severe forms of spina bifida, the site of an Olympic athlete training facility and operator of one of the largest and highest performing clinically integrated networks in the region. Orlando Health is a statutory teaching system that pioneers life-changing medical research. The 3,200-bed system includes 15 wholly-owned hospitals and emergency departments; rehabilitation services, cancer and heart institutes, imaging and laboratory services, wound care centers, physician offices for adults and pediatrics, skilled nursing facilities, an in-patient behavioral health facility, home healthcare services in partnership with LHC Group, and urgent care centers in partnership with CareSpot Urgent Care. Nearly 4,200 physicians, representing more than 80 medical specialties and subspecialties have privileges across the Orlando Health system, which employs nearly 22,000 team members. In FY20, Orlando Health served nearly 150,000 inpatients and nearly 3.1 million outpatients. During that same time period, Orlando Health provided approximately $760 million in total value to the communities it serves in the form of charity care, community benefit programs and services, community building activities and more. Additional information can be found at http://www.orlandohealth.com.
